Therapeutic Effect of Upadacitinib in Primary Sjögren's Syndrome
NCT06862284
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Primary Sjögren's Syndrome (pSS)
Interventions
DRUG:
Upadacitinib (ABT-494)
DRUG:
Hydroxychloroquine (HCQ)
Sponsor
Peking University People's Hospital